My Profile

Search abstracts

Lewis Sheiner


2017
Budapest, Hungary



2016
Lisboa, Portugal

2015
Hersonissos, Crete, Greece

2014
Alicante, Spain

2013
Glasgow, Scotland

2012
Venice, Italy

2011
Athens, Greece

2010
Berlin, Germany

2009
St. Petersburg, Russia

2008
Marseille, France

2007
København, Denmark

2006
Brugge/Bruges, Belgium

2005
Pamplona, Spain

2004
Uppsala, Sweden

2003
Verona, Italy

2002
Paris, France

2001
Basel, Switzerland

2000
Salamanca, Spain

1999
Saintes, France

1998
Wuppertal, Germany

1997
Glasgow, Scotland

1996
Sandwich, UK

1995
Frankfurt, Germany

1994
Greenford, UK

1993
Paris, France

1992
Basel, Switzerland



Printable version

PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe.
ISSN 1871-6032

Reference:
PAGE 24 (2015) Abstr 3622 [www.page-meeting.org/?abstract=3622]


PDF poster/presentation:
Click to open Click to open

Software Demonstration


S-01 Sebastian Wicha TDMx: A web-application for therapeutic drug monitoring enhanced by pharmacometrics

Sebastian G. Wicha (1), Martin G. Kees (1,2), Alexander Solms (3), Iris K. Minichmayr (1), Alexander Kratzer (4), Charlotte Kloft (1)

(1) Dept. of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Germany, (2) Dept. of Anaesthesiology and Intensive Care, Charité Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany, (3) Institute of Mathematics, University of Potsdam, Germany, (4) Hospital Pharmacy, University Hospital Regensburg, Germany

Background: Pharmacometric models have evolved as useful tools to quantify and explain pharmacokinetic (PK) variability between patients and to explore its resulting pharmacodynamic (PD) consequences e.g. on probabilities of target attainment (PTA) of anti-infectives. The application of pharmacometric PK/PD models in clinical practice is yet limited, as available software is either difficult to use or lacks functionality. Hence, we aimed to develop ‘TDMx’ (www.tdmx.eu), an easy-to-use, but powerful modular software tool for bedside dosing decisions, making use of state-of-the-art pharmacometric techniques such as (i) probability of target attainment analysis without requiring drug measurements, (ii) Bayesian PK estimation and definite PK/PD target attainment analysis if drug measurements are available and (iii) (adaptive) optimal design to sample at the most informative time points. As a starting point, population PK models for the anti-infectives gentamicin, amikacin, meropenem and piperacillin have been implemented. 

TDMx features:

  • TDMx is freely accessible via a user-friendly web interface from any common (modern) browser and quickly provides answers to the clinically relevant TDM-related questions.
  • Patient module: Input module for all available patient data (e.g. demographics, laboratory measurements) as well as the dosing schedule provided to ‘TDMx’. 
  • Probabilistic dosing module: Computes the PTA to select a likely effective dosing regimen solely using patient covariates, e.g. to initiate empiric therapy, or to guide institutions where no drug measurements are available.
  • Bayesian dosing module: Estimates individual PK parameters for definite target attainment analyses if drug measurements are available.
  • Optimal design module: Predicts the most informative sampling time points for precise estimation of either PK parameters (e.g. in a research setting) or PD surrogates (e.g. T>MIC as a relevant PK/PD index in clinical routine).
  • ‘TDMx’ was successfully validated against NONMENTM.

Conclusion: With ‘TDMx’, we provide a user-friendly and powerful web-application, making use of state-of-the art pharmacometric techniques to support bedside dosing decision-making. In comparison to other currently available tools, ‘TDMx’ offers broader functionality and can entirely be used in a web browser.